- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo for PF-05230907
Total 2800 results
-
PfizerCompleted
-
PfizerCompleted
-
PfizerTerminatedIntracerebral HemorrhageSpain, United States, Canada, United Kingdom
-
PfizerCompletedColitis, UlcerativeCanada, United States, France, Netherlands, Germany, Spain, Austria, Hungary, Bulgaria, Poland, Romania
-
AblynxCompleted
-
PfizerTerminatedCachexiaUnited States
-
PfizerTerminated
-
PfizerRecruitingPulmonary Arterial HypertensionUnited States
-
PfizerCompletedHealthy | Chronic Rhinosinusitis With Nasal Polyps | Atopic DermatitisUnited States
-
PfizerCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
PfizerCompletedAnorexia | Breast Cancer | Fatigue | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Cachexia | Non-small Cell Lung Cancer | Loss of AppetiteUnited States, Canada
-
PfizerTerminated
-
PfizerCompletedPsoriasisCanada, United States, Japan, Poland
-
PfizerCompleted
-
PfizerCompleted
-
PfizerTerminated
-
PfizerCompleted
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
PfizerNot yet recruiting
-
PfizerTerminatedDiabetes Mellitus, Type 2United States
-
PfizerCompleted
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerCompletedUlcerative ColitisUnited States, Spain, Israel, Korea, Republic of, Russian Federation, Turkey, Czechia, Hungary, Italy, Poland, Bulgaria, Denmark, Germany, Serbia, Austria, Slovakia, Ukraine, Georgia, Romania
-
PfizerCompleted
-
PfizerRecruitingShingles | Human | Herpes Zoster InfectionUnited States
-
PfizerRecruitingAtopic DermatitisUnited States, Canada
-
PfizerWithdrawnRespiratory Tract Diseases | Bronchial Diseases | Lung Diseases, Obstructive | Asthma, Bronchial
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
PfizerCompleted
-
PfizerCompletedSchizophreniaUnited States
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Canada
-
PfizerCompletedHyperlipidemiaUnited States, Canada
-
PfizerCompletedRheumatoid ArthritisUnited States, Spain, Czechia, Serbia, Singapore, Taiwan, Hungary, Ukraine, Hong Kong, Korea, Republic of, Russian Federation, Slovakia, Turkey
-
PfizerTerminated
-
PfizerCompletedLiver Fibrosis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
PfizerCompletedType 2 Diabetes MellitusJapan
-
PfizerCompletedDiabetes Mellitus, Type 1United States
-
PfizerCompleted
-
PfizerActive, not recruitingDuchenne Muscular DystrophyUnited States, Spain, Belgium, Korea, Republic of, Taiwan, Canada, Australia, Germany, Japan, France, Italy, United Kingdom, Russian Federation, Israel, Switzerland
-
PfizerCompleted
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerCompletedHealthy | Sickle Cell AnemiaUnited States
-
PfizerCompleted
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedCannabis DependenceUnited States
-
PfizerCompleted
-
PfizerTerminatedDuchenne Muscular DystrophyUnited States, Australia, Canada, United Kingdom, Japan, Bulgaria, Italy, Poland